Our Services: GMP/GxP Consulting
A team of permanent GMP consultants, specialized in various fields of competence, supports you in your tasks and problems with expertise and foresight.
We understand the diverse issues and challenges you face on your way to achieving GMP compliance in the pharmaceutical, biotechnology, ATMP and medical device manufacturing industries - and we develop practical, achievable and cost-effective solutions for you.
Our GMP experts have been providing the highest levels of professionalism and efficiency for over 20 years. We will work on your project in a timely manner and finalize it efficiently.
We can offer GMP services for individual niche solutions for your challenges as well as comprehensive packages that cover all GMP requirements arising in the context of pharmaceutical manufacturing activities. For start-ups, we provide the implementation of a quality management system with all mandatory documents (GMP & GDP).
Furthermore, our team supports the GMP-compliant definition of your process steps and implementation with regard to rooms and equipment (GxP QMS, Gap analysis, qualification & validation).
What kind of support you require: Our GMP consultants will guide you through the process of obtaining your manufacturing authorization and the corresponding GMP certificate.
With us, you avoid delays in your market entry due to a lack of GMP compliance and move your business idea forward as quickly as possible.
We also implement the corresponding GMP-related measures quickly, reliable, and professional if your processes, plants, premises, equipment, or products need to be changed.
Your main contact person will support you throughout the entire project, involving several internal teams depending on the project size.
Ensure the quality of your products by setting up a QMS. Valicare's experts will support you with QM consulting, document preparation & implementation.
To ensure the proper quality of pharmaceutical and biotechnological products, numerous sets of rules of Good Practices (GxP), have been published.
They cover a wide range of areas to ensure the safety of medicinal products, such as:
All these regulations require a dedicated quality management system for the respective companies.
Standard Operating Procedures (SOPs) as well as all supplementary quality management documents (QMS) should be optimally tailored to each other and to the company's organization to enable efficient and faultless work in accordance with the respective rules.
The relevant supervisory authority checks the legally compliant design of your QMS and can only grant your company a permission for the activity in question if all processes are described in compliance with the regulations.
Our GMP/GxP experts keep you on the safe side. We offer professional support in the implementation of GxP-compliant quality management systems.
You can commission us with the comprehensive conception and document creation for your QMS or have our experts accompany or implement the processing of individual focal points.
Relevant guidelines:
GMP: Good manufacturing practice | European Medicines Agency (europa.eu)
GCP: ICH E6 (R2) Good clinical practice | European Medicines Agency (europa.eu)
GLP: Good laboratory practice compliance | European Medicines Agency (europa.eu)
GDP: Good distribution practice | European Medicines Agency (europa.eu)
GMP concepts describe general procedures for quality assurance tools essential for operation of a GMP system.
This comprises a multitude of documents like work instructions, standard operating procedures, concepts for training, qualification, validation, deviation and change control management, handling of OOS results, self-inspections and much more.
As these documents are the key to an efficient and error free operation of the GMP unit, they should fit to each other and to the size of the customer side. An essential prerequisite for the efficient and practical application of the quality assurance tools is the deep knowledge about options and variation.
This and the exact description of the requirements and processes allows the adequate adaption of the tools to the real need of your GMP system.
We offer two different approaches to implement GMP concepts:
Get in contact with us now and tell us in which steps of GMP concept development you need support. We will promptly provide you with an offer for consulting services or creation of a concept. Together we find the ideal solutions for your project!
Design review is a well-established GMP consultancy service. By this procedure planned or already built technical equipment and installations are approved on quality by design criteria, suitability and GMP compliance.
The normal scope of a design review could range from viewing a single room or a whole facility. Besides GMP compliance the production capacity and customers product spectrum play a substantial role in the evaluation process.
Our experienced consultants have already executed countless design reviews in over 20 years.
We can therefore offer you this consulting service in each mode usual in the market. The design review can often be carried out without a corresponding on-site presence, solely based on the technical documentation about the general and detailed planning of an installation.
Within Valicare GmbH and through the strong cooperation with our parent company Syntegon comprehensive competencies about classical pharmaceutical and biotechnological production lines also for advanced therapy medicinal products and special pharmaceutical, exist.
Commonly the design review set up is prepared by one GMP consultant. The documents then are checked and evaluated in presentation mode by two or three experts.
In a protocol or a report of that discussion customer will get detailed descriptions of any inconsistencies or deviations observed. Also, the provided technical and organizational concepts were followed and scrutinized on the basis of known or defined process parameters.
All discussions will be closed results-orientated, and all issues will be evaluated and documented in detail. As a customer, you will receive the report of the discussion. Presentation of the results in front of other corporate representatives is possible on demand.
New construction plans or even the reallocation or change of use of a pharmaceutical plant is often the reason for a layout review.
In most cases, the customer's request relates to production areas, but warehouses or laboratories can also be included.
The GMP layout review is part of the classic design review, which is understood as a documented and systematic analysis of a pharmaceutical plant or equipment design according to GMP requirements. The target is to confirm the GMP compliance ofthe design or to identify existing violations and gaps and define corrective solutions.
As part of the GMP layout review, the following topics are considered based on GMP requirements and target-oriented suitability:
SOPs, documents, basic concepts (e.g., hygiene) and the QA system can also be part of the review which is initially carried out on a document basis. If an on-site assessment is required, this can be included at the customer's request.
The assessment of the current planning status according to GMP aspects and the state of the art will be summarized in a review report with proposed measures to improve or ensure GMP compliance.
Are you planning a new plant or the improvement of an existing plant and want to assure that it fulfills GMP requirements?
Then let your GMP layout created or checked by our experienced GMP consultants and technically skilled experts. Knowing what is important, saves time and effort.
Gap analysis is a classical consulting tool to align the current with the target status. It relates either to the entire GMP system of a regulated company or to individual subareas.
This includes for example, qualification, validation and deviation or change management. The Gap analysis is an active comparison of the established current state with the requirements specified by local or international GMP regulations.
The definition of the scope to be analyzed is the responsibility of the client. In case of comprehensive gap analyses, the GMP/GxP consultant performing the analysis may recommend clarification of interfaces or transitions between individual analyses.
Our team of experts has successfully carried out many gap analyses in over the last 20 years and offers this consulting service for all GMP systems.
If you are in the process of preparing for an internal, external, or upcoming regulatory inspection, we can support you with full commitment and professional expertise by our trained and experienced consultants.
This is what a typical procedure looks like: The GMP consultant first checks the company-specific documentation and creates a gap analysis plan. Based on this gap analysis plan, the analysis on-site will be conducted.
The results of documents and on-site checks are documented and the observations and identified deviations concerning GMP requirements are discussed. On the last day of the analysis period, the consultant supplements the deficiencies listed in the final report with proposals for appropriate corrective actions and with addressed associated regulations.
Thanks to our extensive team of consultants, we are usually able to carry out the requested Gap analysis in a timely manner.
Most of our natural scientists and engineers are familiar with being in management positions and, if required, also within your company.
Our employees represent expertise and competence in nearly all positions of the quality management functions (quality management representative, qualification & validation manager, GMP training manager, etc.).
Whether you need personnel compensation for parental leave or for other short-term vacancies - we offer you the right interim manager for every requirement profile.
We generally limit this service to a maximum of 12 months and only compensate for leadership positions where our employees contribute their expertise and dedication.
As a special service each interim manager has personnel back up at Valicare GmbH office, who is well-informed about the current situation at the customer-site, so that he or she can replace the interim manager without a long transition period, if this will be necessary.
Continuity as well as additional availability during capacity intensive business periods is ensured.
Our interim managers are very flexible, and their work is charged on hourly basis only. A fixed price offer including all incidentals can be submitted on special request.
Do you currently have a requirement and need to fill a leadership position on an interim basis? Ask us about suitable profiles for your temporary vacancy.
The EU GMP Guidelines as well as ICH Q10 and the national AMWHV (German Ordinance for the Manufacture of Medicinal Products and Active Pharmaceutical Ingredients, Arzneimittel- und Wirkstoffherstellungsverordnung) specify requirements for assuring quality of the product between the customer and contractor or supplier.
The aim of supplier qualification is, on the one hand, to safeguard supply chains throughout the product lifecycle and, on the other hand, to ensure robust internal processes in compliance with the relevant regulatory requirements.
Supplier qualifications are risk-based, with the scope and depth of the assessment depending on the process-specific risk level.
As part of risk management and on the basis of regulatory requirements, audits must be carried out by adequately trained personnel from the manufacturer or by third parties on site at the supplier's premises or by means of questionnaire audits, depending on the criticality of the goods/services.
Furthermore, already qualified suppliers must be regularly re-evaluated or requalified.
Assured supply chain with qualified suppliers and robust processes is ultimately the basis for reducing complaints and ensuring medicinal product safety.
Thus, all supplier qualification actions contribute to the overall goals of medicinal product safety, efficiency and compliance.
Do you need support or advice on supplier qualification? Contact us and tell us about your requirements. Together we find the best possible solution.
Relevant Regulations:
AMWHV
EU GMP Guideline, Parts I and II
ICH Q10 Pharmaceutical Quality System
Prior to the introduction of medicinal products to the market, the regulations of Good Practice (GxP) have to be followed during production and development.
These include, Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP) and Good Distribution Practice (GDP).
During the product life cycle of a medicinal product, quality requirements increase continuously from research and development through the different clinical phases to market maturity.
Already during development and formulation, the first compliance measures for Good Manufacturing Practice (GMP) must be implemented. These basically include all GMP relevant topics which are to be applied on a risk-based approach according to the respective development stage.
In case medicinal products shall be manufactured for a clinical trial, a manufacturing authorisation and a corresponding GMP certificate are already required for this purpose.1
Upon request, the respective regulatory authority will conduct an on-site inspection to verify compliance with national law and EU GMP requirements.
Prior to this, an appropriate quality management system must have been established, which demonstrates suitable measures to ensure the proper quality and safety of the medicinal products according to EU standards.
In particular, the following aspects must be documented and ensured: description of the internal processes, the suitability of all premises and facilities, the conformity of materials used, the qualification of the personnel and the quality of external services.
We offer full services along the entire product life cycle:
including the relevant application to obtain or extend your authorization/ GMP certificate (according to § 13 or § 72 AMG):
Do you need support or advice on one or more of these topics? Our experienced professionals will accelerate the entry of your product into the pharmaceutical/biotech market.
1 for the manufacturing authorisation: according to § 13 (1) of the German Medicines Act; for the import authorisation: according to § 72 of the German Medicines Act; format according to: https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-10/basicformat_manufacturersauthorisation_en.pdf
Dr. Ellen Sons-Brinkmann
Tel: +49 69 153 293 709
Mail.: ellen.sons-brinkmann@valicare.com